Smouldering myeloma: detection, risk stratification and defining a new standard of care
New CLL treatments, the standard of care and the importance of clonal evolution
How are drug development and clinical trials changing?
Message to mantle cell lymphoma physicians and patients
COMy 2017: Day 1 discussion on progress in multiple myeloma, patient advocacy and drug costs
Arnon Nagler et al.